John M. Evans Insider Trades & Stock Holdings

CEO · Beam Therapeutics Inc. · Latest filing Oct 16, 2026

John M. Evans, CEO at Beam Therapeutics Inc. has 2 Form 4 trades on file since Oct 15, 2026. Open-market activity: 0 purchases ($0) and 2 sales ($1.19M), net -$1.19M. Latest filing: disposed of 25K shares of $BEAM on Oct 16, 2026 at $23.98.

Trades on file

2

Open-market bought

$0

Open-market sold

$1.19M

Net open-market

-$1.19M

Shares held ($BEAM)

1.05M

Latest filing

Oct 16, 2026

Shares held by John M. Evans

• $BEAM1.05M sh

Shares owned after the most recent Form 4 for each company.

All insider trades by John M. Evans

Date	Ticker	Type	Shares	Price	Value	Owned after	ΔOwn	1W	1M	6M	Role	Filing	Story
Oct 16, 2026	$BEAM	Sell (Open-market sale) 10b5-1	25K	$23.98	$599.60K	1.05M	-2.33%				CEO	SEC	Read
Oct 15, 2026	$BEAM	Sell (Open-market sale) 10b5-1	25K	$23.57	$589.15K	1.05M	-2.33%				CEO	SEC	Read

"Buy" means shares acquired on the Form 4 (including grants and option exercises); "Sell" means shares disposed. 1W / 1M / 6M = how the stock moved after the trade.

Stocks John M. Evans traded

• $BEAM

Frequently asked questions

Has John M. Evans been buying or selling stock?

John M. Evans has 0 open-market purchases and 2 open-market sales on file, net -$1.19M. Grants, option exercises and tax withholding are listed separately because they are not open-market trades.

What was John M. Evans's latest insider trade?

disposed of 25K shares of $BEAM on Oct 16, 2026 at $23.98.

Data comes from public SEC Form 4 and 13F filings and STOCK Act disclosures. Dates are the trade or filing date reported. This page is for research only and is not investment advice.